CDK4/6 inhibitors: a brief overview and prospective research directions
Author:
Affiliation:
1. Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagar, Mysuru-570015, Karnataka, India
Abstract
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2021/RA/D1RA03820F
Reference70 articles.
1. Cancer , https://www.who.int/news-room/fact-sheets/detail/cancer , accessed March 25, 2021
2. Prevalence and prevention of cardiovascular disease and diabetes mellitus
3. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
4. P.Gupta , S.Narayanan and D.-H.Yang , CDK Inhibitors as Sensitizing Agents for Cancer Chemotherapy , in Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy , Elsevier Inc. , 2019 , pp. 125–149 , 10.1016/b978-0-12-816435-8.00009-2
5. The history and future of targeting cyclin-dependent kinases in cancer therapy
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51 signaling pathway genes in MCF-7 and MDA-MB-231 cells;PLOS ONE;2024-08-28
2. The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-06
3. Slower CDK4 and faster CDK2 activation in the cell cycle;Structure;2024-08
4. Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma;Cancer Biology & Therapy;2024-08
5. The role and mechanism of engineered nanovesicles derived from hair follicle mesenchymal stem cells in the treatment of UVB‐induced skin photoaging;Journal of Cosmetic Dermatology;2024-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3